847361-73-3

Upstream product

• 847358-98-9 N-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-4-fluoro-L-leucine 
• 443918-99-8 (4S,5R)-4-amino-5-methyldihydrofuran-3-(2H)-one hydrochloride 
• 770703-10-1 (4S,5R)-4-amino-5-methyldihydrofuran-3(2H)-one 

Relevant academic research and scientific papers

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

The present invention relates to a novel class of compounds mainly, leucinamide-amino-carboxylate derivatives of formula (I) wherein Y is CR1R2, O, S, -SO2, C=0 or NR9; Z is CR1R2, O, S, -S

CATHEPSIN INHIBITORS

This invention relates to a novel class of compounds, represented by the formula (I) below, wherein the meanings of R1, R2, R3 and R4 are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis, osteoarthritis and rheumatoid arthritis.